Biomarker Pursuit: Keeping Current With Novel Biomarkers in Hematology/Oncology

In the popular biomarker-focused session at JADPRO Live 2022, presenters paired biomarkers with tumor types for which their expression is most commonly used to determine targeted therapy, identified key assays used to measure common biomarkers, and reviewed recommendations and guidelines for biomark...

Descripción completa

Detalles Bibliográficos
Autores principales: Faiman, Beth, Kurtin, Sandra E., Persinger, Rasheda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2023
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184845/
https://www.ncbi.nlm.nih.gov/pubmed/37197733
http://dx.doi.org/10.6004/jadpro.2023.14.3.8
_version_ 1785042222367899648
author Faiman, Beth
Kurtin, Sandra E.
Persinger, Rasheda
author_facet Faiman, Beth
Kurtin, Sandra E.
Persinger, Rasheda
author_sort Faiman, Beth
collection PubMed
description In the popular biomarker-focused session at JADPRO Live 2022, presenters paired biomarkers with tumor types for which their expression is most commonly used to determine targeted therapy, identified key assays used to measure common biomarkers, and reviewed recommendations and guidelines for biomarker testing.
format Online
Article
Text
id pubmed-10184845
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Harborside Press LLC
record_format MEDLINE/PubMed
spelling pubmed-101848452023-05-16 Biomarker Pursuit: Keeping Current With Novel Biomarkers in Hematology/Oncology Faiman, Beth Kurtin, Sandra E. Persinger, Rasheda J Adv Pract Oncol Meeting Reports In the popular biomarker-focused session at JADPRO Live 2022, presenters paired biomarkers with tumor types for which their expression is most commonly used to determine targeted therapy, identified key assays used to measure common biomarkers, and reviewed recommendations and guidelines for biomarker testing. Harborside Press LLC 2023-04 2023-04-01 /pmc/articles/PMC10184845/ /pubmed/37197733 http://dx.doi.org/10.6004/jadpro.2023.14.3.8 Text en © 2023 Harborside™ https://creativecommons.org/licenses/by-nc-nd/3.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Reports
Faiman, Beth
Kurtin, Sandra E.
Persinger, Rasheda
Biomarker Pursuit: Keeping Current With Novel Biomarkers in Hematology/Oncology
title Biomarker Pursuit: Keeping Current With Novel Biomarkers in Hematology/Oncology
title_full Biomarker Pursuit: Keeping Current With Novel Biomarkers in Hematology/Oncology
title_fullStr Biomarker Pursuit: Keeping Current With Novel Biomarkers in Hematology/Oncology
title_full_unstemmed Biomarker Pursuit: Keeping Current With Novel Biomarkers in Hematology/Oncology
title_short Biomarker Pursuit: Keeping Current With Novel Biomarkers in Hematology/Oncology
title_sort biomarker pursuit: keeping current with novel biomarkers in hematology/oncology
topic Meeting Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184845/
https://www.ncbi.nlm.nih.gov/pubmed/37197733
http://dx.doi.org/10.6004/jadpro.2023.14.3.8
work_keys_str_mv AT faimanbeth biomarkerpursuitkeepingcurrentwithnovelbiomarkersinhematologyoncology
AT kurtinsandrae biomarkerpursuitkeepingcurrentwithnovelbiomarkersinhematologyoncology
AT persingerrasheda biomarkerpursuitkeepingcurrentwithnovelbiomarkersinhematologyoncology

Ejemplares similares